Ensuring medication adherence with direct oral anticoagulant drugs: Lessons from adherence with vitamin K antagonists (VKAs)

Thrombosis Research

Volumn 133, Issue 5, 2014, Pages 699-704

  Di Minno, Alessandro ^a   Spadarella, Gaia ^a   Tufano, Antonella ^a   Prisco, Domenico ^b   Di Minno, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Communication cooperation between patients and doctors; Direct oral anticoagulants; Every day practice; Ex vivo laboratory tests; Patient's awareness; Persistence

Indexed keywords

ANTICOAGULANT AGENT; VITAMIN K GROUP; WARFARIN;

ANTAGONISTS AND INHIBITORS; HUMAN; MEDICATION COMPLIANCE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTICOAGULANTS; HUMANS; MEDICATION ADHERENCE; VITAMIN K; WARFARIN;

EID: 84898830021     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.01.016     Document Type: Review

References (71)

1. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
2. D. Bergqvist, J.I. Arcelus, and P. Felicissimo ETHOS investigators. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry Thromb Haemost 107 2 Feb 2012 280 287
3. A. Mauskop, and W.B. Borden Predictors of statin adherence Curr Cardiol Rep 13 2011 553 558
4. P.P. Kneeland, and M.C. Fang Current issues in patient adherence and-persistence: focus on anticoagulants for the treatment and prevention-of thromboembolism Patient Prefer Adherence 4 2010 51 60
5. M.A. Fischer, M.R. Stedman, J. Lii, C. Vogeli, W.H. Shrank, and M.A. Brookhart et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions J Gen Intern Med 25 2010 284 290
6. S.A. Doggrell Adherence to medicines in the older aged with chronic conditions: does intervention by an allied health professional help? Drugs Aging 27 2010 239 254
7. S. Coccheri, and D. Orlando New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures Intern Emerg Med 8 2013 115 122
8. L.S. Wann, A.B. Curtis, K.A. Ellenbogen, N.A. Estes, M.D. Ezekowitz, and W.M. Jackman et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines Circulation 127 18 May 7 2013 1916 1926
9. D. Garcia, E. Libby, and M.A. Crowther The new oral anticoagulants Blood 115 2010 15 20
10. M.J. Alberts Antithrombotic therapy for secondary stroke prevention Continuum (Minneap Minn) 17 Dec 2011 1255 1266 [6 2ndary, Stroke Prevention]
11. M.N. Di Minno, A. Russolillo, M. Camera, A. Parolari, and E. Tremoli Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients Expert Opin Emerg Drugs 18 2013 9 23
12. R.A. Rodriguez, M. Carrier, and P.S. Wells Non-adherence to new oral anticoagulants: a reason for concern during-long-term anticoagulation? J Thromb Haemost 11 2013 390 394
13. S. Schulman, C. Kearon, A.K. Kakkar, P. Mismetti, S. Schellong, and H. Eriksson et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
14. S. Schulman, B. Shortt, M. Robinson, and J.W. Eikelboom Adherence to anticoagulant treatment with dabigatran in a real world setting J Thromb Haemost 11 7 Jul 2013 1295 1299
15. D.G. Pittman, C. Fenton, W. Chen, S. Haffner, and M. Pendergrass Relation of statin non adherence and treatment intensification Am J Cardiol 110 2012 1459 1463
16. B. Lebel, M. Malherbe, S. Gouzy, J.J. Parienti, J.J. Dutheil, and M.T. Barrellier et al. Oral thromboprophylaxis following total-hip replacement: the issue of compliance Orthop Traum Surg Res 98 2012 186 192
17. M.C. Fang, A.S. Go, Y. Chang, L. Borowsky, N.K. Pomernacki, and D.E. Singer et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation J Am Coll Cardiol 51 2008 810 815
18. J. Mant, F.D.R. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, and G. YH Lip et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
19. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696
20. E.L. De Schryver, J. van Gijn, L.J. Kappelle, P.J. Koudstaal, and A. Algra Dutch TIA trial and SPIRIT study groups. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke J Neurol 252 2005 1316 1321
21. S. Werth, C. Koehler, V. Gelbricht, U. Haensel, L. Tittl, and I. Beyer-Westendorf et al. Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation - First Results of the Prospective Noac Registry. (NCT01588119) Blood (ASH Annual Meeting Abstracts) 120 2012 1156
22. D.C. Grabowski, D.N. Lakdawalla, D.P. Goldman, M. Eber, L.Z. Liu, and T. Abdelgawad et al. The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment Health Aff (Millwood) 31 2012 2276 2285
23. J.H. Arnsten, J.M. Gelfand, and D.E. Singer Determinants of compliance with anticoagulation: A case-control study Am J Med 103 1997 11 17
24. T. Nikolaus, W. Kruse, M. Bach, N. Specht-Leible, P. Oster, and G. Schlierf Elderly patients' problems with medication. An in-hospital and follow-up study Eur J Clin Pharmacol 49 4 1996 255 259
25. J.A. Johnston, R.J. Cluxton Jr., P.C. Heaton, J.J. Guo, C.J. Moomaw, and M.H. Eckman Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation Arch Intern Med 163 2003 1705 1710
26. T.J. Bungard, W.A. Ghali, K.K. Teo, F.A. McAlister, and R.T. Tsuyuki Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46
27. A.S. Go, E.M. Hylek, L.H. Borowsky, K.A. Phillips, J.V. Selby, and D.E. Singer Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934
28. J. Ansell, J. Hirsh, A. Hylek, A. Jacobson, M. Crowther, and G. Palareti Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl. 2008 160S 198S
29. A.D. Waterman, P.E. Milligan, L. Bayer, G.A. Banet, S.K. Gatchel, and B.F. Gage Effect of warfarin nonadherence on control of the International Normalized Ratio Am J Health Syst Pharm 61 2004 1258 1264
30. G. Palareti, C. Legnani, G. Guazzaloca, V. Lelia, B. Cosmi, and B. Lunghi et al. Risks factors for highly unstable response to oral anticoagulation: a case-control study Br J Haematol 129 2005 72 78
31. L.H. Cavallari, J.L. Aston, K.M. Momary, N.L. Shapiro, S.R. Patel, and E.A. Nutescu Predictors of unstable anticoagulation in African Americans J Thromb Thrombolysis 27 2009 430 437
32. H.D. White, M. Gruber, J. Feyzi, S. Kaatz, H.-F. Tse, and S. Husted et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V Arch Intern Med 167 2007 239 245
33. N.J. Davis, H.H. Billett, H.W. Cohen, and J.H. Arnsten Impact of adherence, knowledge, and quality of life on anticoagulation control Ann Pharmacother 39 2005 632 636
34. A.Y. Shen, J.F. Yao, S.S. Brar, M.B. Jorgensen, and W. Chen Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation J Am Coll Cardiol 50 2007 309 315
35. E. Birman-Deych, M.J. Radford, D.S. Nilasena, and B.F. Gage Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation Stroke 37 2006 1070 1074
36. J.P. Ediger, J.R. Walker, L. Graff, L. Lix, I. Clara, and P. Rawsthorne et al. Predictors of medication adherence in inflammatory bowel disease Am J Gastroenterol 120 2007 1417 1426
37. M.C. Fang, E.L. Machtinger, F. Wang, and D. Schillinger Health literacy and anticoagulation-related outcomes among patients taking warfarin J Gen Intern Med 21 2006 841 846
38. F. Trachtenberg, E. Dugan, and M.A. Hall How patients' trust relates to their involvement in medical care J Fam Pract 54 2005 344 352
39. J.A. Cramer Effect of partial compliance on cardiovascular medication-effectiveness Heart 88 2002 203 206
40. S.E. Kimmel, Z. Chen, M. Price, C.S. Parker, J.P. Metlay, and J.D. Christie et al. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study Arch Intern Med 167 2007 229 235
41. A.B. Platt, A.R. Localio, C.M. Brensinger, D.G. Cruess, J.D. Christie, and R. Gross et al. Risk factors for nonadherence-to warfarin: results from the IN-RANGE study Pharmacoepidemiol Drug Saf 17 2008 853 860
42. D.G. Cruess, A.R. Localio, A.B. Platt, C.M. Brensinger, J.D. Christie, and R. Gross et al. Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient-anticoagulation clinics Int J Behav Med 17 2010 33 42
43. D.P. Schauer, C.J. Moomaw, M. Wess, T. Webb, and M.H. Eckman Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin J Gen Intern Med 20 2005 1114 1119
44. D. Schillinger, F. Wang, M. Rodriguez, A. Bindman, and E.L. Machtinger The importance of establishing regimen concordance in preventing medication errors in anticoagulant care J Health Commun 11 2006 555 567
45. J.A. Johnston, R.J. Cluxton Jr., P.C. Heaton, J.J. Guo, C.J. Moomaw, and M.H. Eckman Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation Arch Intern Med 163 2003 1705 1710
46. I.A. Orensky, and D.A. Holdford Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic Pharmacotherapy 25 2005 1801 1808
47. G.C. Dantas, B.V. Thompson, J.A. Manson, C.S. Tracy, and R.E. Upshur Patients' perspectives on taking warfarin: qualitative study in family practice BMC Fam Pract 5 2004 15
48. G.S. Calip, D.M. Boudreau, and E.T. Loggers Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment Breast Cancer Res Treat 138 2013 225 233
49. J. Lindhardsen, O. Ahlehoff, G.H. Gislason, O.R. Madsen, J.B. Olesen, and C. Torp-Pedersen et al. Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study Ann Rheum Dis 71 2012 1496 1501
50. D. Barcellona, P. Contu, G.G. Sorano, V. Pengo, and F. Marongiu The management of oral anticoagulant therapy: the patient's point of view Thromb Haemost 83 2000 49 53
51. D. Berti, J.M. Hendriks, A. Brandes, C. Deaton, H.J. Crijns, and A.J. Camm et al. A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice Eur Heart J 34 35 2013 2725 2730
52. D. Barcellona, P. Contu, and F. Marongiu Patient education and oral anticoagulant therapy Haematologica 87 2002 1081 1086
53. R. Griffo, M. Ambrosetti, R. Tramarin, F. Fattirolli, P.L. Temporelli, and A.R. Vestri et al. for the ICAROS investigators Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey Int J Cardiol 167 4 2013 1390 1395
54. A. Bitton, N.K. Choudhry, O.S. Matlin, K. Swanton, and W.H. Shrank The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review Am J Med 126 357 2013 357.e7 357.e27
55. E. Berglund, P. Lytsy, and R. Westerling Adherence to and beliefs in lipid-lowering medical treatments: A structural equation modeling approach including the necessity-concern framework Patient Educ Couns 91 2013 105 112
56. P.T. Nieuwkerk, M.C. Nierman, M.N. Vissers, M. Locadia, P. Greggers-Peusch, and L.P. Knape et al. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk Am J Cardiol 110 2012 666 672
57. G. Di Minno, E. Ricciardi, and A. Scalera Laboratory tests during direct oral anticoagulant treatment? Int Emerg Med 8 2013 367 370
58. V. Pengo, L. Crippa, A. Falanga, G. Finazzi, F. Marongiu, and Palareti et al. Italian Federation of Thrombosis Centers. Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA) Thromb Haemost 106 2011 868 876
59. H. Heidbuchel, P. Verhamme, M. Alings, M. Antz, W. Hacke, and J. Oldgren et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation Europace 15 2013 625 651
60. C. Stavropoulou Non-adherence to medication and doctor-patient relationship: Evidence from a European survey Patient Educ Couns 83 2011 7 13
61. K. Zolnierek, and R. Di Matteo Physician Communication and Patient Adherence to Treatment. A Meta-Analysis Medical Care 47 2009 826 834
62. E. Remor Predictors of treatment difficulties and satisfaction with haemophilia therapy in adults Haemophilia 17 2011 e901 e905
63. A.J. Baca-Osorio, R. Perez-Gonzalez, F.J. Tinahones, and R. Gomez-Huelgas Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study Eur J Prev Cardiol 19 2012 1074 1081
64. J.M. Hendriks, R. de Wit, H.J. Crijns, H.J. Vrijhoef, M.H. Prins, and R. Pisters et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation Eur Heart J 33 2012 2692 2699
65. S.F. Derose, K. Green, E. Marrett, K. Tunceli, T.C. Cheetham, and V.Y. Chiu et al. Automated outreach to increase primary adherence to cholesterol-lowering medications JAMA Intern Med 173 2013 38 43
66. J. Wei, I. Hollin, and S. Kachnowski A review of the use of mobile-phone text messaging in clinical and healthy behaviour interventions J Telemed Telecare 17 2011 41 48
67. Q. Liu, K. Abba, M.M. Alejandria, V.M. Balanag, R.P. Berba, and M.A. Lansang Reminder systems and late patient tracers in the diagnosis-and management of tuberculosis Cochrane Database Syst Rev 4 2008 CD006594
68. S. Kopecky New anticoagulants for stroke prophylaxis in atrial fibrillation: assessing the impact on medication adherence Am J Cardiovasc Drugs 12 2012 287 294
69. C.I. Coleman, M.S. Roberts, D.M. Sobieraj, S. Lee, T. Alam, and R. Kaur et al. Effect of dosing frequency on chronic cardiovascular disease medication adherence Curr Med Res Opin 28 2012 1 12
70. F. Laliberte, W.W. Nelson, P. Lefebvre, J.R. Schein, J. Rondeau-Leclaire, and M.S. Duh Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients Adv Ther 29 2012 675 690
71. A.J. Claxton, J. Cramer, and C. Pierce A systematic review of the associations between dose regimens and medication compliance Clin Ther 23 2001 1296 1310